Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation and pharmacological targeting of RAD51 in cancer
McKenzie K. Grundy, Ronald J. Buckanovich, Kara A. Bernstein
NAR Cancer (2020) Vol. 2, Iss. 3
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Targeting DNA damage response pathways in cancer
Florian J. Groelly, Matthew Fawkes, Rebecca A. Dagg, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 2, pp. 78-94
Closed Access | Times Cited: 446
Leveraging the replication stress response to optimize cancer therapy
Emily Cybulla, Alessandro Vindigni
Nature reviews. Cancer (2022) Vol. 23, Iss. 1, pp. 6-24
Open Access | Times Cited: 70
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 17
METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis
Enjie Li, Mingyue Xia, Yu Du, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 49
Inhibiting homologous recombination by targeting RAD51 protein
Alexandre Demeyer, Houda Benhelli‐Mokrani, Benoı̂t Chénais, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188597-188597
Open Access | Times Cited: 42
Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
Shiro Takamatsu, J. Brown, Ken Yamaguchi, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 37
Cryo-EM structures of RAD51 assembled on nucleosomes containing a DSB site
Takuro Shioi, Suguru Hatazawa, Eriko Oya, et al.
Nature (2024) Vol. 628, Iss. 8006, pp. 212-220
Open Access | Times Cited: 6
New RAD51 Inhibitors to Target Homologous Recombination in Human Cells
Irina Shkundina, Alexander Gall, Alexej Dick, et al.
Genes (2021) Vol. 12, Iss. 6, pp. 920-920
Open Access | Times Cited: 35
Small-Molecule–Mediated Stabilization of PP2A Modulates the Homologous Recombination Pathway and Potentiates DNA Damage-Induced Cell Death
Rita A. Avelar, Amy J. Armstrong, Gracie Carvette, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 5, pp. 599-615
Open Access | Times Cited: 15
EGFR-mediated Rad51 expression potentiates intrinsic resistance in prostate cancer via EMT and DNA repair pathways
Mohit Rajput, Ragini Singh, Navneendra Singh, et al.
Life Sciences (2021) Vol. 286, pp. 120031-120031
Closed Access | Times Cited: 32
Noncanonical Roles of RAD51
Mélissa Thomas, Caroline Dubacq, Elise Rabut, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1169-1169
Open Access | Times Cited: 12
Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair
Jeremy M. Kelm, Amirreza Samarbakhsh, Athira Pillai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
RAD51 protects against nonconservative DNA double-strand break repair through a nonenzymatic function
Ayeong So, Elodie Dardillac, Ali Akbar Muhammad, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 5, pp. 2651-2666
Open Access | Times Cited: 17
Homologous recombination, cancer and the ‘RAD51 paradox’
Gabriel Matos‐Rodrigues, Josée Guirouilh‐Barbat, Emmanuelle Martini, et al.
NAR Cancer (2021) Vol. 3, Iss. 2
Open Access | Times Cited: 23
DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia
Stephanie Kim, Seung Cho Lee, Bumjin Lim, et al.
Prostate International (2023) Vol. 11, Iss. 2, pp. 113-121
Open Access | Times Cited: 9
Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways
Leonie Schürmann, Lena Schumacher, Katharina Roquette, et al.
Cancer Letters (2021) Vol. 520, pp. 361-373
Closed Access | Times Cited: 19
Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3
Vanessa Wachholz, Al‐Hassan M. Mustafa, Yanira Zeyn, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 177-193
Open Access | Times Cited: 19
Bioactivity of PEGylated Graphene Oxide Nanoparticles Combined with Near-Infrared Laser Irradiation Studied in Colorectal Carcinoma Cells
Natalia Krasteva, Dessislava Staneva, Bela Vasileva, et al.
Nanomaterials (2021) Vol. 11, Iss. 11, pp. 3061-3061
Open Access | Times Cited: 19
In vivo reduction of RAD51‐mediated homologous recombination triggers aging but impairs oncogenesis
Gabriel Matos‐Rodrigues, Vilma Barroca, Ali‐Akbar Muhammad, et al.
The EMBO Journal (2023) Vol. 42, Iss. 20
Open Access | Times Cited: 7
Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
Shiro Takamatsu, J. Brown, Ken Yamaguchi, et al.
JCO Precision Oncology (2021), Iss. 5, pp. 1270-1280
Open Access | Times Cited: 16
An update on small molecule compounds targeting synthetic lethality for cancer therapy
Jiaxiang Luo, Yang Li, Yiwen Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116804-116804
Closed Access | Times Cited: 2
RAD51 paralogs: Expanding roles in replication stress responses and repair
Debanjali Bhattacharya, Satyaranjan Sahoo, Tarun Nagraj, et al.
Current Opinion in Pharmacology (2022) Vol. 67, pp. 102313-102313
Closed Access | Times Cited: 10
Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies
Lisa Hong, Dennis Braden, Yaoning Zhao, et al.
Redox Biology (2023) Vol. 66, pp. 102856-102856
Open Access | Times Cited: 5
Genetically Regulated Gene Expression in the Brain Associated With Chronic Pain: Relationships With Clinical Traits and Potential for Drug Repurposing
Keira J.A. Johnston, Alanna C. Cote, Emily M. Hicks, et al.
Biological Psychiatry (2023) Vol. 95, Iss. 8, pp. 745-761
Open Access | Times Cited: 5
Determinants of Homologous Recombination Deficiency in Pancreatic Cancer
Max M. Wattenberg, Kim A. Reiss
Cancers (2021) Vol. 13, Iss. 18, pp. 4716-4716
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top